SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan

SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan

Background: As of January 2022, more than 57 million cases of COVID-19 have been reported in the United States. Three primary COVID-19 vaccines are widely available: Pfizer (BNT162b2), Moderna (mRNA-1273), and Johnson & Johnson’s-Janssen (JNJ-78436735). The vaccines are effective but do not prev...

Full description

Bibliographic Details
Main Authors:	Sydney Fine, Kellee Necaise, Alexandra Hayward, Anurag Malani
Format:	Article
Language:	English
Published:	Cambridge University Press 2022-07-01
Series:	Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:	https://www.cambridge.org/core/product/identifier/S2732494X22001334/type/journal_article

Similar Items

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection
by: Silvia D’Orso, et al.
Published: (2023-11-01)

Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review
by: Qinglu Fan, et al.
Published: (2022-11-01)

Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
by: Diane Uschner, et al.
Published: (2022-11-01)

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
by: Disha Bhavsar, et al.
Published: (2023-12-01)

SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
by: Alessio Danilo Inchingolo, et al.
Published: (2021-03-01)

Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections
by: Stefania Arsuffi, et al.
Published: (2023-05-01)

Breakthrough SARS-CoV-2 infections after vaccination: a critical review
by: Zeinab Mohseni Afshar, et al.
Published: (2022-11-01)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
by: Jing Zou, et al.
Published: (2022-08-01)

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
by: Jozef Dingemans, et al.
Published: (2022-11-01)

A SARS-CoV-2 outbreak due to vaccine breakthrough in an acute-care hospital
by: Se Yoon Park, et al.
Published: (2022-07-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
by: Tafadzwa Dzinamarira, et al.
Published: (2022-02-01)

SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
by: Eva A.M. Baerends, et al.
Published: (2023-09-01)

Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
by: Mohamed Ibraheem Mahmoud Ahmed, et al.
Published: (2022-12-01)

Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico
by: Kame A. Galán-Huerta, et al.
Published: (2022-01-01)

The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data
by: Meghana Kshirsagar, et al.
Published: (2022-11-01)

Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study
by: Mohamed Hadi Mohamed Abdelhamid, et al.
Published: (2022-01-01)

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
by: Priyamadhaba Behera, et al.
Published: (2022-01-01)

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
by: Jernej Pušnik, et al.
Published: (2023-02-01)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
by: Maria I. Ventura, et al.
Published: (2022-12-01)

SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India
by: Prakash P. Doke, et al.
Published: (2023-01-01)

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
by: Gerco den Hartog, et al.
Published: (2023-10-01)

Genetic relatedness among Neisseria gonorrhoeae isolates in southeastern Michigan
by: Anita Shallal, et al.
Published: (2023-06-01)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
by: Ye-Fan Hu, et al.
Published: (2022-03-01)

Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy)
by: Paolo Basso, et al.
Published: (2022-02-01)

Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
by: Yihuang Liu, et al.
Published: (2023-11-01)

Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
by: Qinghong Fan, et al.
Published: (2022-07-01)

The descriptive epidemiology of pre-omicron SARS-CoV-2 breakthrough infections and severe outcomes in Manitoba, Canada
by: Souradet Y. Shaw, et al.
Published: (2024-01-01)

Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients
by: Michalski Aleksander, et al.
Published: (2023-12-01)

Risk Stratification of SARS-CoV-2 Breakthrough Infections Based on an Outbreak at a Student Festive Event
by: Ralph Bertram, et al.
Published: (2022-03-01)

SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
by: Xiaohui Jing, et al.
Published: (2023-09-01)

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
by: Michael S. Seaman, et al.
Published: (2022-10-01)

Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave
by: Anna Herting, et al.
Published: (2023-01-01)

Postvaccination breakthrough SARS-CoV-2 infections among adults in Malaysia and attitudes towards future vaccination
by: Praneetha Kumar Nair, et al.
Published: (2023-01-01)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
by: Matthieu Buscot, et al.
Published: (2023-03-01)

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
by: Xiaomeng He, et al.
Published: (2023-06-01)

Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients
by: Reem S. Almaghrabi, et al.
Published: (2022-01-01)

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
by: José Luis Piñana, et al.
Published: (2023-01-01)

Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study
by: Anthony Rooney, et al.
Published: (2022-05-01)